An assessment of the prevalence of NSAID prescriptions in primary care in those with ischaemic heart disease (IHD) or risk factors for IHD

被引：0

作者：

Orr, C. ^{[1
]}

O'Connor, C. ^{[1
]}

Kavanagh, J. ^{[1
]}

机构：

[1] Mercer Med Ctr, Dept Med RCSI, Dublin, Ireland

来源：

IRISH JOURNAL OF MEDICAL SCIENCE | 2014年 / 183卷

关键词：

NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MYOCARDIAL-INFARCTION;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S107 / S108

页数：2

共 50 条

[1] NEW DATA, NEW PROBLEM; ASSESSING THE PREVALENCE OF NSAID PRESCRIBING IN PRIMARY CARE IN THOSE WITH A BACKGROUND OF ISCHAEMIC HEART DISEASE (IHD) OR RISK FACTORS FOR IHD
Orr, C.
O'Connor, C.
Kavanagh, J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 121 - 121
[2] NEW DATA, NEW PROBLEM; ASSESSING THE PREVALENCE OF NSAID PRESCRIBING IN PRIMARY CARE IN THOSE WITH A BACKGROUND OF ISCHAEMIC HEART DISEASE (IHD) OR RISK FACTORS FOR IHD
Orr, C.
O'Connor, C.
Kavanagh, J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1042 - 1042
[3] Risk factors for ischaemic heart disease (IHD) in rheumatoid arthritis (RA).
Banks, MJ
Bacon, PA
Flint, J
Forsey, P
Kitas, GD
[J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S345 - S345
[4] AETIOLOGY OF ISCHAEMIC HEART DISEASE (IHD)
MORRIS, JN
[J]. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1962, 55 (08): : 693 - 695
[5] Classical risk factors for ischaemic heart disease (IHD) in rheumatoid arthritis (RA)
Erb, N.
Banks, M. J.
Rowe, I. F.
Kitas, G. D.
[J]. RHEUMATOLOGY, 2001, 40 : 70 - 71
[6] Expression and prevalence of ischaemic heart disease (IHD) in rheumatoid arthritis (RA).
Banks, MJ
Flint, EJ
Bacon, PA
Kitas, GD
[J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S209 - S209
[7] Classical risk factors for ischaemic heart disease (IHD) and their modification in patients with rheumatoid arthritis (RA).
Erb, N
Banks, MJ
Rowe, IF
Dudley, RDK
[J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S53 - S53
[8] Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD)
Meade, TW
Cooper, JA
Miller, GJ
[J]. THROMBOSIS AND HAEMOSTASIS, 1997, 78 (02) : 926 - 929
[9] THE IMPORTANCE OF RISK-FACTORS IN PRIMARY IHD PREVENTION
BOUDIK, F
BULTAS, J
TOMECKOVA, M
JEDLICKA, J
KRUPICKA, F
KARETOVA, D
HAJKOVA, M
KMONICEK, P
PICK, P
HOLODNIOK, M
[J]. SBORNIK LEKARSKY, 1987, 89 (8-9): : 230 - 239
[10] Is antithrombin III a risk factor for ischaemic heart disease (IHD) in Warsaw Pol-Monica population?
Pytlak, A
Piotrowski, W
Rywik, S
[J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 166 - 167

← 1 2 3 4 5 →